STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. STOK
  4. [EFFECT] Stoke Therapeutics, Inc. SEC Filing

[EFFECT] Stoke Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 11, 2025 4:00 P.M.
Form: S-3
CIK: 0001623526
Company Name: Stoke Therapeutics, Inc.
File Number: 333-288583

Source: View Original Filing on SEC EDGAR

Stock STOK logo
Stoke Therapeutics

NASDAQ:STOK

STOK Rankings

#2277 Ranked by Market Cap
N/A Ranked by Dividends

STOK Latest News

Nov 18, 2025
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Nov 5, 2025
Stoke Therapeutics to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
Nov 4, 2025
Stoke Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
Oct 30, 2025
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2025 Business and Financial Updates
Oct 20, 2025
Stoke Therapeutics Presents Two-Year Natural History Data from Patients with Autosomal Dominant Optic Atrophy (ADOA)

STOK Latest SEC Filings

Nov 26, 2025
[Form 4] Stoke Therapeutics, Inc. Insider Trading Activity
Nov 18, 2025
[Form 4] Stoke Therapeutics, Inc. Insider Trading Activity
Nov 5, 2025
[Form 4] Stoke Therapeutics, Inc. Insider Trading Activity
Nov 4, 2025
[10-Q] Stoke Therapeutics, Inc. Quarterly Earnings Report
Nov 4, 2025
[8-K] Stoke Therapeutics, Inc. Reports Material Event

STOK Stock Data

1.70B
51.58M
4.46%
118.44%
19.6%
Biotechnology
Pharmaceutical Preparations
Link
United States
BEDFORD